Actuate Therapeutics registers 1.33M shares for resale by investors

* Actuate Therapeutics (NASDAQ:ACTU [https://seekingalpha.com/symbol/ACTU]) filed a prospectus for resale of 1.33M common shares by existing investors. The offering includes 666,497 outstanding shares and 666,497 shares issuable upon warrant exercise.
* Actuate will not receive proceeds from the resale of shares, but will receive funds from any warrant exercises.
* Source: SEC filing [https://seekingalpha.com/filing/10221272]

MORE ON ACTUATE THERAPEUTICS, INC.

* Actuate Therapeutics: Elraglusib trial meets key endpoint in pancreatic cancer [https://seekingalpha.com/news/4454055-actuate-therapeutics-elraglusib-trial-meets-key-endpoint-in-pancreatic-cancer]
* Actuate jumps as lead drug succeeds in mid-stage trial for pancreatic cancer [https://seekingalpha.com/news/4441834-actuate-stock-jumps-cancer-trial-data]
* Historical earnings data for Actuate Therapeutics, Inc. [https://seekingalpha.com/symbol/ACTU/earnings]
* Financial information for Actuate Therapeutics, Inc. [https://seekingalpha.com/symbol/ACTU/income-statement]